- Home
- JNVR vs LGVN Comparison
JNVR vs LGVN Comparison
Compare JNVR & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JNVR
- LGVN
- Stock Information
- Founded
- JNVR 2018
- LGVN 2014
- Country
- JNVR United States
- LGVN United States
- Employees
- JNVR N/A
- LGVN N/A
- Industry
- JNVR Finance: Consumer Services
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- JNVR Finance
- LGVN Health Care
- Exchange
- JNVR Nasdaq
- LGVN Nasdaq
- Market Cap
- JNVR N/A
- LGVN 30.0M
- IPO Year
- JNVR 2023
- LGVN 2021
- Fundamental
- Price
- JNVR $0.55
- LGVN $2.05
- Analyst Decision
- JNVR
- LGVN Strong Buy
- Analyst Count
- JNVR 0
- LGVN 2
- Target Price
- JNVR N/A
- LGVN $8.00
- AVG Volume (30 Days)
- JNVR 21.7K
- LGVN 393.9K
- Earning Date
- JNVR 11-12-2024
- LGVN 11-08-2024
- Dividend Yield
- JNVR N/A
- LGVN N/A
- EPS Growth
- JNVR N/A
- LGVN N/A
- EPS
- JNVR N/A
- LGVN N/A
- Revenue
- JNVR $1,786,085.00
- LGVN $1,229,000.00
- Revenue This Year
- JNVR N/A
- LGVN $161.78
- Revenue Next Year
- JNVR N/A
- LGVN $8.62
- P/E Ratio
- JNVR N/A
- LGVN N/A
- Revenue Growth
- JNVR N/A
- LGVN 39.34
- 52 Week Low
- JNVR $0.42
- LGVN $0.77
- 52 Week High
- JNVR $1.84
- LGVN $23.90
- Technical
- Relative Strength Index (RSI)
- JNVR 49.64
- LGVN 52.20
- Support Level
- JNVR $0.49
- LGVN $1.76
- Resistance Level
- JNVR $0.62
- LGVN $2.26
- Average True Range (ATR)
- JNVR 0.06
- LGVN 0.12
- MACD
- JNVR -0.00
- LGVN 0.05
- Stochastic Oscillator
- JNVR 58.69
- LGVN 58.00
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.